drugset / Trial / NCT00910676

Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors

NCT00910676

Phase 2 Completed 30 enrolled Centre Oscar Lambret Roche Pharma AG · collab
NaSingle-groupOpen-labelPrevention

Summary

Patients will receive local prophylactic treatment (Diprosone cream) during 8 weeks from the beginning of the EGF-R inhibitors treatment, on the areas of the body susceptible to be affected by folliculitis.

Timeline

Start
2007-10
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject betamethasone dipropionate Small molecule 60 g Topical